NRSN
Neurosense Therapeutics Ltd.
NASDAQ · Healthcare · Biotechnology · IL
$6.66
−0.97%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 3.14x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- -8.09x
- Price / sales
- —
- Price / cash flow
- -3.44x
Enterprise value
- Enterprise value
- $12.6M
- EV / sales
- —
- EV / EBITDA
- -1.14x
- EV / EBIT
- -1.14x
- Market cap
- $12.6M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Dec 1, 2025